PTH and COVID-19: Recent studies have also identified a distinct osteometabolic phenotype in COVID-19, marked by hypocalcemia, chronic vitamin D deficiency, impaired parathyroid hormone response, and increased bone fragility, which predispose individuals to skeletal complications such as vertebral fractures and are associated with worse clinical outcomes [14,17].